- Home
- XFOR vs HQI Comparison
XFOR vs HQI Comparison
Compare XFOR & HQI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XFOR | HQI |
|---|---|---|
| Founded | 2014 | 2002 |
| Country | United States | United States |
| Employees | N/A | 75000 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 288.5M | 232.1M |
| IPO Year | 2017 | 2008 |
Fundamental Metrics
Financial Performance| Metric | XFOR | HQI |
|---|---|---|
| Price | $3.17 | $17.57 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 2 |
| Target Price | $11.60 | ★ $19.00 |
| AVG Volume (30 Days) | ★ 646.1K | 26.6K |
| Earning Date | 11-04-2026 | 11-12-2026 |
| Dividend Yield | N/A | ★ 1.40% |
| EPS Growth | N/A | ★ 73.08 |
| EPS | N/A | ★ 0.31 |
| Revenue | $6,500,000.00 | ★ $30,640,000.00 |
| Revenue This Year | N/A | $0.54 |
| Revenue Next Year | N/A | $5.47 |
| P/E Ratio | ★ N/A | $57.19 |
| Revenue Growth | ★ 150.00 | N/A |
| 52 Week Low | $2.43 | $7.38 |
| 52 Week High | $4.83 | $20.84 |
Technical Indicators
Market Signals| Indicator | XFOR | HQI |
|---|---|---|
| Relative Strength Index (RSI) | 50.33 | 53.98 |
| Support Level | $2.83 | $15.28 |
| Resistance Level | $3.52 | $18.49 |
| Average True Range (ATR) | 0.26 | 1.11 |
| MACD | 0.02 | 0.08 |
| Stochastic Oscillator | 53.47 | 64.63 |
Price Performance
Historical ComparisonAbout XFOR X4 Pharmaceuticals Inc.
X4 Pharmaceuticals Inc is a biopharmaceutical company developing and commercializing novel therapeutics for the treatment of rare hematology diseases. The Company's clinical candidate is mavorixafor, a small molecule antagonist of the chemokine receptor CXCR4 that is being developed as an oral, once-daily therapy. It can increase the mobilization of mature, functional white blood cells from the bone marrow into the bloodstream. It also has two pre-clinical candidates X4P-003 and X4P-002 which are CXCR4 antagonists with different properties.
About HQI HireQuest Inc. (DE)
HireQuest Inc is a nationwide franchisor of offices providing direct-dispatch, executive search, and commercial staffing solutions in the light industrial and blue-collar segments of the staffing industry and traditional commercial staffing. The company's franchisees provide various types of temporary personnel through two business models operating under the trade names HireQuest Direct, HireQuest, Snelling, DriverQuest, HireQuest Health, Northbound Executive Search, and MRI. The company's primary source of revenue is royalty fees based on the operation of its franchised offices.